Nguyen Laboratory
Key investigator
- Alexander H. Nguyen, MD, PhD
Liver lipid metabolism
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common liver disease in America, affecting one in three adults. While most patients with this condition have an excellent prognosis, a subset of patients develop steatohepatitis, which is characterized by hepatocyte stress and immune cell activation. This chronic damage and inflammation lead to fibrosis, end-stage liver disease, and cancer.
The goal of our research is to understand how lipid metabolism contributes to the development of steatohepatitis. We study genes and cellular processes that function to protect hepatocytes from environmental and genetic stressors. We utilize a broad range of techniques to understand these processes including molecular assays, biochemistry, cellular models, animal models, and patient data. By understanding these pathways, we hope to develop molecular diagnostic, prognostic, and therapeutic tools to improve the clinical management of steatotic liver disease.
Honors and awards
- NIH-NIDDK K08 grant, 2024
- Dr. Nguyen, assistant clinical professor of medicine, was awarded a K08 Clinical Investigator Award from the National Institute of Diabetes and Digestive and Kidney Diseases. This five-year award of $853,000 supports Dr. Nguyen’s research on the “Role of a Novel Methyltransferase in Liver Lipid Metabolism.” His work aims to characterize how a methyltransferase regulates cellular cholesterol metabolism and contributes to the development of steatotic liver disease.
- DDW Basic Science Travel Award, 2024
- Research Scholar Award, American Gastroenterological Association, 2023
- Emerging Generation Award, American Society for Clinical Investigation, 2023
- Resident/Fellow Ambassador, American Association for the Study of Liver Diseases, 2019
- Emerging Liver Scholar Award, American Association for the Study of Liver Diseases, 2018
About Dr. Nguyen
Dr. Nguyen earned his bachelor’s degree in molecular and cell biology from the University of California, Berkeley. He earned his medical degree from Weill Cornell Medical College and doctoral degree from The Rockefeller University through the Tri-Institutional MD-PhD Program. His doctoral research investigated the metabolic mechanisms driving colorectal cancer metastasis using large-scale functional genomic screening and xenograft models. He completed his internal medicine residency and gastroenterology fellowship at UCLA, where he conducted postdoctoral research on liver lipid metabolism. His fellowship research was supported by the UCLA Specialty Training and Advanced Research (STAR) program and an NIH T32 GI training grant.
In 2023, Dr. Nguyen joined the faculty at the UCLA Vatche and Tamar Manoukian Division of Digestive Diseases. His research focuses on characterizing the regulation of liver lipid metabolism to advance the diagnosis and treatment of steatotic liver disease. His contributions as a physician-scientist have been recognized with an ASCI Emerging Generation Award, an AGA Research Scholar Award, and an NIH K08 Clinical Investigator Award. Dr. Nguyen is board certified in internal medicine and gastroenterology. Profile on Google Scholar
Lab members
Kristin Bartlett
Alison Blencowe
Gabriel Pe Manuel Ordonez
Adam Mahdi, MSc
Khoi Pham
Undergraduate students
- Marguerette Bui
- Zaid Vellani
- Yueshui Helen Zhang
Selected publications
- Uchiyama LF, Ordonez GPM, Pham KT, Kennelly JP, López Rodríguez M, Tran L, Tontonoz P, Nguyen A. PPARɑ variant V227A reduces plasma triglycerides through enhanced lipoprotein lipolysis. Journal of Lipid Research. 2025 May 1;66(5):100806
Contact us
If you would like to contact us, please email Dr. Zander Nguyen.
If you are interested in joining our research group, please include a cover letter detailing your relevant accomplishments and your CV.